We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 1.40
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.20 (14.286%)
Open: 1.50
High: 1.50
Low: 1.50
Prev. Close: 1.50
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: AVI Japan Disappointed By Fourth Quarter

Thu, 14th Jan 2021 21:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

AVI Japan Opportunity Trust PLC - invests in portfolio of 20 to 30 Japanese stocks - Says small-cap companies in Japan have been "largely ignored" by stock market investors. For the quarter ended December 31, the MSCI Japan Small Cap Index, in GBP, returned 2.2% while its larger counterpart, MSCI Japan, returned 9.0%. Says own return of 1.0% "disappointing" considering the very strong earnings recovery reported by portfolio companies. "This quarter's earnings season showed the resilience of our companies, with weighted sales and profits of our portfolio falling year-on-year by 4.5% and 6.8%, compared to the companies in the MSCI Japan Small Cap Index whose sales and profits fell 4.5% and 20%. More importantly is that our companies have shown they are on the path to recovery, with quarter-on-quarter profits increasing by a whopping 55%," AVI adds.

----------

Beximco Pharmaceuticals Ltd - Bangladesh-based generic pharmaceutical maker - Says supply and distribution of 30 million doses of the Oxford University-AstraZeneca PLC SARS-CoV-2 vaccine in Bangladesh expected towards the end of January, with further deliveries taking place on a monthly basis thereafter until June 2021. Under the agreement signed in November last year, Beximco Pharma is acting as the exclusive distributor for the Vaccine in Bangladesh. The company, which is paying USD8, in cost and freight, for each private pay market dose, is targeting a retail price of about USD14 inclusive of vaccination charges although the final pricing decision is subject to approval from the Bangladesh Director General of Drug Administration.

----------

Orosur Mining Inc - South American gold exploration and development company - Net loss for the three months to November 30 narrows to USD264,000 from USD367,000 the year before. Corporate & admin expenses fall to USD288,000 from USD358,000.

----------

Trident Royalties PLC - mining royalty and streaming company - Says it is "delighted" by the exploration progress Apollo Consolidated has made at the 1 million ounce Lake Rebecca gold project, in Western Australia, over which Trident holds a 1.5% net smelter royalty. Chief Executive Adam Davidson says: "Since completing the royalty acquisition on October 29, 2020, Apollo has announced some very encouraging infill and exploratory drilling results which bode well for significant upgrades in the expected Q2 2021 mineral resource estimate update, and which serve to further de-risk future technical studies on the project as Apollo seeks to fast track the project into mine construction." Strong gold drill intercepts have been returned in expected positions whilst additional intercepts have extended the mineral resource block model in places, Trident says.

----------

Amur Minerals Corp - nickel-copper sulphide mineral exploration and development in far east of Russia - Receives its fourth quarter interest payment of USD164,768 based on the USD4.7 million convertible loan note investment for the resumption of production at the Northern Territories, Australia Roper Bar iron ore project operated by Nathan River Resources Pte Ltd. Chief Executive Robin Young says: "The Nathan River Resources' Roper Bar iron ore operation has benefitted from the more than 50% run up in iron ore prices during 2020. Despite the Covid-19 pandemic, iron ore availability to maintain China's continued and robust steel demand has and is projected to provide strong price support for the iron ore industry over the course of the next year. This setting indicates the likely existence of a ready market for the Roper ores."

----------

IQ-AI Ltd - medical software company with headquarters in Jersey - Says development pipeline is extensive and growing. Chief Executive Trevor Brown adds: "We are operating at a time of rapid innovation where the development and clinical translation of medical AI solutions will provide a paradigm shift in routine clinical practice, resulting in improved patient care. The company is optimistic that substantial progress will be made in all these initiatives during 2021."

----------

Strategic Minerals PLC - battery materials minerals company with asset in Australia - Sales from Cobre in three months to December 31 sales up over 20% year on year to USD747,000. "Sales remained robust and the positive annual growth highlights the strength of demand being maintained despite the Covid-19 pandemic," company says. Production at Cobre in final quarter of December at 12,845 tonnes. Chief Executive John Peters adds: "Continued strong sales at Cobre, combined with the December capital raise, have placed the company in a solid position to move forward in 2021 with a goal of commencing a second income stream from copper production at Leigh Creek, subject to finance. Concurrently, we continue our endeavours to progress the Redmoor project."

----------

Zephyr Energy PLC - UK-based oil and gas company focused on the US upstream oil and gas sector - Says State 16-2 stratigraphic test well was successfully drilled to a measured depth of 9,745 feet total depth at Paradox Basin, Utah, US. Drilling operations were safe and effective, Zephyr says, and were conducted in accordance with Covid-19 related guidance and restrictions, and were completed well within the company's forecast timeframe. Zephyr's primary objective was to drill and set casing at 6,437 feet measured depth in order to provide a host wellbore for a future horizontal side track. The company achieved this goal within 13 days from spud - and subsequently reached TD within 19 days of spud, a marked improvement over historical drilling efforts in this part of the Paradox Basin.

----------

Mosman Oil & Gas Ltd - oil exploration, development, and production company - Total barrels of oil equivalent production in six months to December 31 down to 31,753 from 37,226 in the previous six months. Net attributable boe down to 8,650 in the second half from 9,890 in the first half. Says there was continued disruption from the pandemic along with the requirement for certain workovers at Stanley, but significantly the Falcon-1 well commenced production. Mosman has an opportunity to participate in several potential wells in 2021. The intention is to participate in drilling at least one well each quarter, company adds.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to raise GBP300,000 gross proceeds via the issue of 20.0 million new shares at a price of 1.5p each. The issue price represents a discount of 32% to the company's Wednesday closing price of 2.2p. The placing includes a broker option for existing shareholders for up to 6.7 million new shares, which would raise an additional GBP100,000. Admission of the new placing and broker option shares is expected to occur on or around March 1.

Read more
9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Administration.

Read more
2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD100,000 grant by the Musella Foundation For Brain Tumor Research & Information Inc. Explains that the grant will help to support the launch of an intermediate group expanded access programme, which is focused on giving brain tumour patients access to oral gallium maltolate, outside of an ongoing Phase One clinical trial at the Medical College of Wisconsin. The grant will be used to facilitate the expanded access programme, including writing and submitting the study protocol, patient screening and on-boarding.

Read more
10 Jan 2024 11:48

IQ-AI falls after subsidiary notes launch of treatment access scheme

(Alliance News) - IQ-AI Ltd shares fell on Wednesday, after it said its subsidiary Imaging Biometrics LLC is launching an intermediate population cohort expanded access programme for oral gallium maltolate.

Read more
19 Dec 2023 17:00

IQ-AI firm gets US FDA fast-track status for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Tuesday said the US Food & Drug Administration has granted 'fast-track" designation for oral gallium maltolate, which is its subsidiary Imaging Biometrics LLC's therapeutic for the treatment of adult patients with relapsed or refractory glioblastoma.

Read more
5 Dec 2023 11:49

IQ-AI stock rises on positive interim results from glioblastoma trial

(Alliance News) - IQ-AI Ltd on Tuesday reported positive results from Phase 1 of an on-going study for its investigational monotherapy oral gallium maltolate.

Read more
8 Nov 2023 12:04

IQ-AI says Imaging Biometrics submits paediatric rare disease request

(Alliance News) - IQ-AI Ltd on Wednesday said its wholly-owned subsidiary Imaging Biometrics LLC has submitted a paediatric rare disease request to the US Food & Drug Administration for its gallium maltolate therapy.

Read more
18 Oct 2023 17:11

IN BRIEF: IQ-AI subsidiary "central" to "landmark" brain cancer study

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Notes its wholly-owned subsidiary, Imaging Biometrics LLC (IB), has announced the results of a "landmark" study. Says the study represents the first large-scale characterization of the invasive tumour margins of high-grade glioma using multi-regional genomic/transcriptomic sequencing with spatially matched MRI measurements in glioma. High-grade glioma is a deadly brain cancer. Explains that Imaging Biometrics' IB Neuro's dynamic susceptibility contrast magnetic resonance imaging software was central to the study.

Read more
9 Oct 2023 12:09

IN BRIEF: IQ-AI subsidiary wins orphan drug designation from US FDA

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Wholly-owned subsidiary Imaging Biometrics LLC is granted an orphan drug designation from the US Food & Drug Administration for gallium maltolate for the treatment of atypical teratoid rhabdoid tumour. Notes this is the second orphan designation granted to gallium maltolate this year.

Read more
8 Sep 2023 10:25

IQ-AI notes vindication of subsidiary's reduced gadolinium approach

(Alliance News) - IQ-AI Ltd on Friday noted that studies by its subsidiary Imaging Biometrics LLC validated the dosing approach of Imaging's MRI-focused IB Neuro.

Read more
18 Aug 2023 12:17

IQ-AI shares jump on subsidiary's GE Healthcare deal

(Alliance News) - IQ-AI Ltd on Friday said its wholly-owned subsidiary Imaging Biometrics LLC has signed a deal with GE HealthCare Technologies Inc.

Read more
17 Aug 2023 11:21

IQ-AI interim loss narrows amid higher revenue, lower expenses

(Alliance News) - IQ-AI Ltd on Thursday announced a slightly lower loss for the six months to June 30, as revenue was up and administrative expenses were lower.

Read more
19 Jul 2023 10:45

IN BRIEF: IQ-AI subsidiary's app adopted by US medical college

IQ-AI Ltd - Jersey-based medical services firm focused on cancer treatment - Says subsidiary Imaging Biometrics LLC's handheld application IB Nimble has been adopted by the Medical College of Wisconsin's Orthopedic Department for use in bone metastases treatment. IB Nimble's designer, Joseph Bovi, is professor of radiation oncology & neurosurgery at MCW. The application was originally designed to help treat brain metastases. IQ-AI says it "provides real-time collaboration amongst multi-disciplinary teams" to "provide optimised treatments faster". Josh McComack, Imaging Biometrics' director of software engineering, says the new installation "demonstrates that IB Nimble is ready for widespread deployment."

Read more
13 Jul 2023 11:36

IN BRIEF: IQ-AI granted orphan drug designation for Gallium Galtolate

IQ-AI Ltd on Thursday - Jersey-based incubator of software and other tools for the treatment of cancer - IQ-AI subsidiary Imaging Biometrics LLC has been granted an orphan drug designation for Gallium Galtolate for the treatment of paediatric glioblastoma multiforme, or GBM, by the US Food & Drug Administration. Says GBM is the most common and aggressive primary brain tumour in adults and children. Imaging Biometrics' application to the FDA was first submitted in April. In June, two pre-clinical studies showed oral GaM inhibits brain tumour growth in children, and the results were consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin.

Read more
27 Jun 2023 11:47

IN BRIEF: IQ-AI notes Gallium Moltate studies on tumour growth

IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC's two new pre-clinical studies show oral Gallium Maltolate inhibits brain tumour growth in children. Says the results are consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin. This follows IB's application for Orphan Drug Designation to the US Food & Drug Administration back in April for the use of GaM in pediatric brain tumours. Notes application is currently under review.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.